Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Exp Med ; 199(8): 1065-75, 2004 Apr 19.
Article in English | MEDLINE | ID: mdl-15078900

ABSTRACT

Identification of cellular factors involved in HIV-1 entry and transmission at mucosal surfaces is critical for understanding viral pathogenesis and development of effective prevention strategies. Here we describe the evaluation of HIV-1 entry inhibitors for their ability to prevent infection of, and dissemination from, human cervical tissue ex vivo. Blockade of CD4 alone or CCR5 and CXCR4 together inhibited localized mucosal infection. However, simultaneous blockade of CD4 and mannose-binding C-type lectin receptors including dendritic cell-specific intercellular adhesion molecule-grabbing integrin was required to inhibit HIV-1 uptake and dissemination by migratory cells. In contrast, direct targeting of HIV-1 by neutralizing mAb b12 and CD4-IgG2 (PRO-542) blocked both localized infection and viral dissemination pathways. Flow cytometric analysis and immunostaining of migratory cells revealed two major populations, CD3(+)HLA-DR(-) and CD3(-)HLA-DR(+) cells, with a significant proportion of the latter also expressing dendritic cell-specific intercellular adhesion molecule-grabbing integrin. Bead depletion studies demonstrated that such HLA-DR(+) cells accounted for as much as 90% of HIV-1 dissemination. Additional studies using immature monocyte-derived dendritic cells demonstrated that although mannose-binding C-type lectin receptors and CD4 are the principal receptors for gp120, other mechanisms may account for virus capture. Our identification of the predominant receptors involved in HIV-1 infection and dissemination within human cervical tissue highlight important targets for microbicide development.


Subject(s)
Cervix Uteri/virology , HIV Infections/prevention & control , Receptors, HIV/antagonists & inhibitors , CCR5 Receptor Antagonists , CD4 Antigens/physiology , CD4-Positive T-Lymphocytes/virology , Cervix Uteri/immunology , Dendritic Cells/virology , Female , HIV Infections/immunology , HIV Infections/transmission , HIV-1 , Humans , In Vitro Techniques , Neutralization Tests , Receptors, CXCR4/antagonists & inhibitors
2.
Blood ; 103(6): 2170-9, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-14630806

ABSTRACT

HIV-1 subverts antigen processing in dendritic cells (DCs) resulting in viral uptake, infection, and transfer to T cells. Although DCs bound monomeric gp120 and HIV-1 similarly, virus rarely colocalized with endolysosomal markers, unlike gp120, suggesting HIV-1 alters endolysosomal trafficking. Virus within DC intracellular compartments rapidly moved to DC-CD4+ lymphocyte synapses when introduced to CD4+ lymphocyte cultures. Although viral harboring and transfer from nonlysosomal compartments was transient, given DC-associated virus protein, nucleic acids, and infectious HIV-1 transfer to CD4+, lymphocytes decayed within 24 hours. However a second long-term transfer phase was apparent in immature DCs after 48 hours as a zidovudine-sensitive rise in proviral DNA. Therefore, DCs transfer HIV-1 to CD4+ lymphocytes in 2 distinct phases. Immature and mature DCs first divert virus from the endolysosomal pathway to the DC-T-cell synapse. Secondly, the later transfer phase from immature DCs is through de novo HIV-1 production. Thus, the controversy of DCs being infected or not infected for the mechanics of viral transfer to CD4+ lymphocytes can be addressed as a function of time.


Subject(s)
2,2'-Dipyridyl/analogs & derivatives , Dendritic Cells/virology , HIV Infections/immunology , HIV-1/growth & development , HIV-1/immunology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/virology , Cells, Cultured , Dendritic Cells/immunology , Dendritic Cells/ultrastructure , Disulfides , HIV Envelope Protein gp120/metabolism , Humans , Microscopy, Electron , Protein Binding , Protein Transport , Simian Immunodeficiency Virus/immunology , Sulfhydryl Reagents
3.
J Acquir Immune Defic Syndr ; 34(1): 7-19, 2003 Sep 01.
Article in English | MEDLINE | ID: mdl-14501788

ABSTRACT

Interactions between HIV-1 and dendritic cells (DCs) play an important role in the initial establishment and spread of infection and development of antiviral immunity. We used chemically inactivated aldrithiol-2 (AT-2) simian immunodeficiency virus (SIV) with functional envelope glycoproteins to study virus interactions with DCs and developed an in vitro system to evaluate the quality of SIV antigen (Ag) presentation by DCs to T cells. AT-2 SIV interacts authentically with T cells and DCs and thus allows assessment of natural SIV-specific responses. CD4+ and CD8+ T cells from blood or lymph nodes of SIV-infected macaques released interferon-gamma (IFN gamma) and proliferated in response to a variety of AT-2 SIV isolates. Responses did not vary significantly as a function of the quantitative envelope glycoprotein content of the virions. Presentation of Ags derived from AT-2 SIV by DCs was more potent than presentation by comparably Ag-loaded monocytes. Interestingly, SIV-pulsed mature DCs stimulated both CD4+ and CD8+ T-cell responses, whereas immature DCs primarily stimulated CD4+ T cells. Further studies using AT-2 inactivated virus may help to define better the details of the virus-DC interactions critical for infection versus induction of antiviral immune responses.


Subject(s)
2,2'-Dipyridyl/analogs & derivatives , Antigen Presentation , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Dendritic Cells/immunology , Lymphocyte Activation , Simian Immunodeficiency Virus/immunology , 2,2'-Dipyridyl/pharmacology , Animals , Cell Differentiation , Dendritic Cells/cytology , Dendritic Cells/virology , Disulfides/pharmacology , Female , Leukocytes, Mononuclear/immunology , Lymph Nodes/immunology , Macaca mulatta , Male , SAIDS Vaccines/immunology , Simian Immunodeficiency Virus/pathogenicity , Simian Immunodeficiency Virus/physiology , Vaccines, Inactivated/immunology
SELECTION OF CITATIONS
SEARCH DETAIL